Aberrant expression of HMB45 and negative PRAME expression in halo nevi

Kristen N Ruby1, Zhongze Li2, Shaofeng Yan1

  • 1Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

Abstract

Insights

Aberrant HMB45 expression is common in halo nevi, mimicking melanoma. Negative PRAME staining helps distinguish halo nevi from melanoma, aiding diagnosis.

Area of Science:

  • Dermatopathology
  • Immunohistochemistry
  • Melanoma Diagnosis

Background:

  • Cutaneous nevi typically exhibit HMB45 gradient and negative PRAME.
  • Melanomas often display irregular HMB45 and positive PRAME staining.
  • Halo nevi can show atypical HMB45 patterns, complicating melanoma differentiation.

Purpose of the Study:

  • To investigate HMB45 and PRAME expression in nevi with the halo phenomenon (NHP).
  • To clarify diagnostic challenges in distinguishing NHP from melanoma.

Main Methods:

  • Evaluated HMB45 and PRAME staining in 20 NHP and 16 conventional nevi.
  • Defined HMB45 gradient as superficial melanocyte positivity.
  • Defined aberrant HMB45 expression as superficial and deep melanocyte positivity.

Main Results:

  • Aberrant HMB45 expression occurred in 50% of NHP cases.
  • Conventional nevi predominantly showed HMB45 gradients (93.7%).
  • PRAME staining was negative in all NHP and conventional nevus cases.

Conclusions:

  • Aberrant HMB45 expression in NHP is a frequent diagnostic pitfall.
  • Negative PRAME immunostaining is a useful marker to differentiate halo nevus from melanoma.